Apoptosis and C1q: Possible explanations for the pathogenesis of systemic lupus erythematosus;Apoptose und C1q: Erklarungsansatze fur die pathogenese des SLE

Zeitschrift fur Rheumatologie

Volumn 59, Issue 3, 2000, Pages 172-175

  Trendelenburg, M ^a   Schifferli, J A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Apoptosis; Autoantibodies; C1q; Complement; SLE

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C1Q;

ANIMAL CELL; ANTIBODY DETECTION; APOPTOSIS; IMMUNE RESPONSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; PATHOGENESIS; REGULATORY MECHANISM; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; AUTOIMMUNE DISEASE; BLOOD; HUMAN; IMMUNOLOGY; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; APOPTOSIS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; COMPLEMENT C1Q; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, KNOCKOUT;

EID: 0033913747     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003930070077     Document Type: Review

References (16)

1. 1. Antes U, Heinz HP, Loos M (1988) Evidence for the presence of Autoantibodies to the Collagen-like Portion of Clq in Systemic Lupus Erythematosus. Arthritis Rheum 31:457-464
2. 2. Botto M, Dell' Agnola C, Bygrave A, Thompson M, Cook T, Petry F, Loos M, Pandolfi PP, Walport M (1998) Homocygous Clq deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nature Genetics 19:56-59
3. 3. Casciola Rosen L, Anhalt G, Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179:1317-1330
4. 4. Coremanns I, Spronk P, Bootsma H, Daha M, van der Voort E, Kate L, Breedveld F, Kallenberg C (1995) Changes in Antibodies to Clq predict renal relapses in Systemic Lupus Erythematosus. Am J Kid Dis 26:595-601
5. 5. Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL (1999) Increased apoptotic peripheral blood neutrophils in systemic lupus erythemadosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 58:309-314
6. 6. Fremeaux-Baechi V, Weiss L, Ddemouchy C, Blouin J, Kazatchkine MD (1996) Autoantibodies to the collagen-like region of Clq are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus. Lupus 5:216-220
7. 7. Gunnarsson I, Rönnelid J, Huang YH, Rogberg S, Nilsson B, Lundberg I, Klareskog L (1997) Association between ongoing anti-Clq antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus. Br J Rheumatol 36:32-37
8. 8. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR (1999) Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41:1241-1250
9. 9. Korb LC, Ahearn JM (1997) Clq binds directly and specifically to surface blebs on apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol 158:4525-4528
10. 10. Levine JS, Koh JS (1999) The role of apoptosis in autoimmunity: immunogen, antigen and accelerant. Semin Nephrol 19:34-47
11. 11. Siegert C, Daha M, Tseng C, Coremanns I, van Es L, Breedveld F (1993) Predictive value of IgG autoantibodies against Clq for nephritis in systemic lupus erythematosus. Ann Rheum Dis 52:851-856
12. 12. Siegert C, Daha M, Westedt ML, van der Voort E, Breedveld F (1991) IgG auto-antibodies against Clq are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol 18:230-234
13. 13. Trendelenburg M, Courvoisier S, Moll, S, Mihatsch M, Späth P, Itin P, Schifferli JA (1999) Hypocomplementemic urticarial vasculitis syndrome (HUVS) or Systemic lupus erythematosus (SLE)? Am J Kid Dis 34:745-751
14. 14. Trendelenburg M, Marfurt J, Gerber I, Tyndall A, Schifferli JA (1999) Lack of occurrence of severe lupus nephritis in anti-Clq autoantibody negative patients. Arthritis Rheum 42:187-188
15. 15. Vaishnaw AK, Toubi E, Ohsako S, Drappa J, Buys S, Estrada J, Sitarz A, Zemel L, Chu JL, Elkon KB (1999) The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations. Arthritis Rheum 42:1833-1842
16. 16. Walport MJ, Davies KA, Botto M (1998) Clq and Systemic Lupus Erythematosus. Immunobiol 199:265-285